Related Experiment Video

Updated: Mar 24, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.4K

Purinergic signaling-induced neuroinflammation and status epilepticus

Tobias Engel1

  • 1a Department of Physiology & Medical Physics , Royal College of Surgeons in Ireland , Dublin 2 , Ireland.

Expert Review of Neurotherapeutics
|March 9, 2016
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ATP signalingP2 receptorsP2X7 receptorStatus epilepticusinflammation

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.8K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

4.1K

Related Experiment Videos

Last Updated: Mar 24, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.4K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.8K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

4.1K

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K

Articles linked to this work by shared authors, journal, and citation graph.

Purinergic signaling: A tribute to Francesco Di Virgilio.

Neuropharmacology·2026

Increased P2X7 level does not affect anxiety or stress-coping behavior in male mice.

Purinergic signalling·2026

Methodological guidelines for P2X receptor assays and data interpretation.

Cell death & disease·2026

Targeting the purinergic P2X7 receptor in epilepsy: Cell types matter.

Neuropharmacology·2026

Shared and distinct microRNA profiles between HT22, N2A and SH-SY5Y cell lines and primary mouse hippocampal neurons.

PloS one·2025

Purinergic modulation of major depressive disorder: Experimental findings, pathogenesis and therapeutic opportunities.

Pharmacological research·2025

The clinical implications of anosognosia in Alzheimer's disease.

Expert review of neurotherapeutics·2026

HAND-IN (hand function after neuromodulation and intensive training in children with cerebral palsy): study protocol for a randomized, triple-blind, controlled trial with embedded implementation and cost-effectiveness analyses.

Expert review of neurotherapeutics·2026

Pediatric multiple sclerosis: a diagnostic overview and the importance of early identification.

Expert review of neurotherapeutics·2026

The recognition, diagnosis, and management of late-onset bipolar disorder.

Expert review of neurotherapeutics·2026

Evaluating seltorexant as a treatment option for major depressive disorder.

Expert review of neurotherapeutics·2026

A status update on the unkept promise of high-frequency spinal cord stimulation for treatment-refractory chronic migraine.

Expert review of neurotherapeutics·2026

Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development.

The Journal of cell biology·2026

Double-blind, sham-controlled, trial of rhythmic 10 Hz median nerve stimulation for the reduction of tics in Tourette syndrome: Analyses of 3-month follow-up data for those receiving active stimulation.

Journal of neuropsychology·2026

Preserved cerebellar functions despite structural degeneration in older adults.

eLife·2026

Spinal Magnetic Resonance Diffusion Tensor Imaging (DTI) in OAB and UAB Caused by Tethered Cord Syndrome (TCS): Can the Yield Be Improved?

Neurourology and urodynamics·2026

Whole-Exome and Whole-Genome Sequencing of Candidate Pharmacogenomic and Schizophrenia-Related Genes in Sudanese Families with Schizophrenia.

Pharmacogenomics and personalized medicine·2026

Neuroendocrine tumors of unknown primary: a case report and review of tumors with gastroenteropancreatic features.

Journal of gastrointestinal oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us